Process for the Production of 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methyl-MORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-Triazol-3-Amine
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 62/905,494, filed Sep 25, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,746,107 | Process for the Production of 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methyl-MORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-Triazol-3-Amine In force · High confidence | Oncoarendi Therapeutics S.A. | In force | High confidence | ||
| US 12,319,677 | Process for the Production of 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methyl-MORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-Triazol-3-Amine In force · High confidence | Molecure S.A. | In force | High confidence |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.